# PCOS Gets a New Name After Years of Patient Advocacy
Polycystic ovary syndrome officially has a new name as of this month, marking the end of a more than decade-long push from patients and health professionals. Over 14,000 people contributed to this decision, including those living with the condition and medical experts.
The change reflects growing recognition that the old name created confusion and stigma. "Polycystic ovary syndrome" suggested the condition centered on cysts in the ovaries, when the reality is far more complex. Many people with PCOS don't actually have ovarian cysts, and the condition affects metabolism, hormones, and fertility in ways the original name failed to capture.
For years, advocates argued the misnomer delayed diagnoses and obscured the condition's true nature. Patients reported feeling dismissed by doctors who focused narrowly on ovarian symptoms while overlooking metabolic dysfunction, insulin resistance, and hormonal imbalances that define the condition for many people.
The new name better reflects current medical understanding. PCOS affects roughly 1 in 10 women of reproductive age, making it one of the most common endocrine disorders. Symptoms range widely. Some people struggle with irregular periods or infertility. Others face insulin resistance, weight gain, or elevated androgen levels. The diversity of presentations has long frustrated doctors and delayed accurate diagnosis.
This renaming effort gained momentum as patient groups, particularly on social media, shared their diagnostic journeys. Many described years of being told their symptoms were "normal" or psychological before finally receiving proper evaluation. The push for change came from organizations like the American College of Obstetricians and Gynecologists and research institutions working alongside patient advocates.
A clearer, more accurate name helps everyone. Patients searching for information find better resources. Doctors recognize the condition's full scope beyond reproductive health.